Jiangsu Delfu Medical Devices Co., Ltd.

Jiangsu Delfu Medical Devices Co., Ltd., established in 2010 and headquartered in Changzhou, Jiangsu Province, is a high-tech manufacturer specializing in precision drug delivery systems. As a subsidiary of Jiangsu Huayang Intelligent Equipment Co., Ltd., the company operates a significant manufacturing footprint across two locations totaling approximately 800,000 square meters. With a workforce of over 1,000 employees, the company is recognized as a "Specialized, Refined, Unique, and New SME" in China, holding over 70 patents and maintaining the distinction of being the only domestic firm with Class III registration for electronic injection pens. The company's extensive product portfolio focuses on micro-dose applications for biopharmaceuticals, including insulin, growth hormones, osteoporosis treatments, and monoclonal antibodies. Core offerings include mechanical and electronic injection pens, IoT-enabled smart injectors, infusion pumps, and wearable drug delivery platforms. Additionally, they provide medical consumables such as safety insulin pen needles, portable nebulizers, and continuous glucose monitoring systems. Their capabilities extend to specialized equipment like linear actuator machines and electro-acupuncture point stimulators. Delfu Medical is a client-driven organization offering comprehensive OEM and ODM services, supported by strong R&D collaborations with top-tier Chinese universities. The company adheres to rigorous international quality standards, holding ISO 13485 and CE certifications. While maintaining a dominant presence in the domestic Chinese market, the company exports to global regions including North America, Europe, and the Middle East, serving pharmaceutical manufacturers, distributors, and healthcare providers.